MAM
IRWD icon

Meeder Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Meeder Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-367
Closed -$4K – 1377
2022
Q3 		$4K Buy
+367
New +$4.16K ﹤0.01% 1645
2020
Q1 		– Sell
-1,118
Closed -$15K – 2413
2019
Q4 		$15K Sell
1,118
-554
-33% -$6.11K ﹤0.01% 1435
2019
Q3 		$14K Buy
1,672
+1,542
+1,186% +$15K ﹤0.01% 1420
2019
Q2 		$1K Sell
130
-1,243
-91% -$13.9K ﹤0.01% 1953
2019
Q1 		$16K Buy
1,373
+819
+148% +$9.15K ﹤0.01% 1129
2018
Q4 		$5K Sell
554
-15,970
-97% -$183K ﹤0.01% 1410
2018
Q3 		$256K Buy
16,524
+4,939
+43% +$78.1K 0.02% 468
2018
Q2 		$186K Buy
+11,585
New +$171K 0.02% 524
2017
Q3 		– Sell
-137
Closed -$2K – 1691
2017
Q2 		$2K Hold
137
– – ﹤0.01% 1404
2017
Q1 		$2K Buy
+137
New +$1.87K ﹤0.01% 1373
2016
Q3 		– Sell
-16,475
Closed -$180K – 845
2016
Q2 		$180K Buy
+16,475
New +$161K 0.02% 581

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Meeder Asset Management's IRWD Position: Q4 2022 in Review

Meeder Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2022, closing a stake of 367 shares — an estimated $4K sold.

Meeder Asset Management first reported a position in IRWD in Q2 2016 and held it in 11 quarters. The position peaked at $256K in Q3 2018. 250 funds tracked by Wall St. Rank hold IRWD as of Q4 2022.

  • Meeder Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 367 Ironwood Pharmaceuticals shares in Q4 2022, an estimated $4K.
  • Meeder Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 11 quarters.
  • Meeder Asset Management's Ironwood Pharmaceuticals position peaked at $256K in Q3 2018.
  • 250 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.